openPR Logo
Press release

Bioburden Testing Market Rapidly Growing in Medical Industry, Competitor Analysis and Top Key Players (Merck, Sigma-Aldrich, SGS, Becton Dickinson, Nelson Lab, ATS Labs) | Forecast 2019 - 2023

10-17-2019 02:17 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Business Industry Reports

Bioburden Testing Market

Bioburden Testing Market

The exclusive research report on the Global Bioburden Testing Market 2019 examines the market in detail along with focusing on significant market dynamics for the key players operating in the market. Global Bioburden Testing Industry research report offers granulated yet in-depth analysis of revenue share, market segments, revenue estimates and various regions across the globe.

Overview of Global Bioburden Testing Market:

This report studies the Global Bioburden Testing Market over the forecast period of 2019 to 2023. The Global Bioburden Testing Market is expected to grow at an impressive Compound Annual Growth Rate (CAGR) from 2019 to 2023.

Some of the major key factors driving the growth of the Global Bioburden Testing Market are growth in the medical devices, pharmaceutical, and biotechnology industries; rising safety concerns related to food and beverage products; and the increasing number of product recalls due to microbial contamination.

Available Exclusive Sample Copy of this Report @ https://www.businessindustryreports.com/sample-request/150957 .

The Global Bioburden Testing Market is segmented on the basis of Type, Application and Region. Based on the Type, the Global Bioburden Testing Market is sub-segmented into Instruments, Consumables and others. On the basis of Application, the Global Bioburden Testing Market is classified into Pharmaceutical, Biotechnology, CMO and others.

In terms of the geographic analysis, The Bioburden Testing Market in North America is expected to grow at the highest CAGR during the forecast period. Moreover, the presence of major players in the Bioburden Testing Market ecosystem results in the increasing adoption of these systems in North America.

Global Bioburden Testing Market Objectives:

1 To provide detailed information regarding key factors (drivers, restraints, opportunities, and industry-specific challenges) influencing the growth of the Bioburden Testing Market

2 To analyze and forecast the size of the Bioburden Testing Market, in terms of value and volume

3 To analyze opportunities in the Bioburden Testing Market for stakeholders and provide a competitive landscape of the market

4 To define, segment, and estimate the Bioburden Testing Market based on deposit type and end-use industry

5 To strategically profile key players and comprehensively analyze their market shares and core competencies

6 To strategically analyze micromarkets with respect to individual growth trends, prospects, and contribution to the total market

7 To forecast the size of market segments, in terms of value, with respect to main regions, namely, Asia Pacific, North America, Europe, the Middle East & Africa, and South America

8 To track and analyze competitive developments, such as new product developments, acquisitions, expansions, partnerships, and collaborations in the Bioburden Testing Market

Purchase this report online with 125 Pages, List of Tables & Figures and in-depth Table of Contents on “Global Bioburden Testing Market Report 2019” @ https://www.businessindustryreports.com/buy-now/150957/single .

Top Leading Key Manufacturers are: Charles River Laboratories International, Sigma-Aldrich, SGS, Wuxi Pharmatech (CAYMAN), Merck, Becton Dickinson, North American Science Associates, Nelson Laboratories, Pacific Biolabs, ATS Labs and others. New product launches and continuous technological innovations are the key strategies adopted by the major players.

Big Industry News:

Merck (October 10, 2019) – Merck Becomes the First to Use Acoustic Technology for Cell Therapy Manufacturing – Merck, a leading science and technology company, today announced it has acquired FloDesign Sonics, of Wilbraham, Massachusetts, USA, developer of a unique acoustic cell processing platform for the industrialization of cell and gene therapy manufacturing. Financial details were not disclosed.

“Chimeric antigen receptor T cell therapies, or CAR-T for short, employs the body’s own immune systems to fight cancer by turning T cells into targeted therapeutics. This revolutionary cancer treatment is challenging and complex, with the process often taking up to a month,” said Udit Batra, member of the Merck Executive Board and CEO, Life Science. “Our acquisition of FloDesign Sonics will industrialize the manufacturing of autologous cell therapy, allowing these types of potentially life-saving treatments to reach more patients, faster.”

Merck is the first company to make acoustic technology available for cell therapy manufacturing. Acoustic cell processing is a disruptive technology that allows for the manipulation of cells with ultrasonic waves. FloDesign Sonics’ acoustic cell processing platform allows enhanced cell washing and concentration for manufacturing cell therapies. The acquisition is a strategic fit for Merck, strengthening the ability alongside pharmaceutical manufacturers to advance cell-based therapies to patients.

Region segment: This report is segmented into several key regions, with sales, revenue, market share (%) and growth Rate (%) of Bioburden Testing in these regions, from 2013 to 2023 (forecast), covering: North America, Europe, Asia Pacific, Middle East & Africa and South America

Grab Your Report at an Impressive Discount @ https://www.businessindustryreports.com/check-discount/150957 .

Major Points in Table of Contents:

Global Bioburden Testing Market Report 2019

1 Bioburden Testing Product Definition

2 Global Bioburden Testing Market Manufacturer Share and Market Overview

2.1 Global Manufacturer Bioburden Testing Shipments

2.2 Global Manufacturer Bioburden Testing Business Revenue

2.3 Global Bioburden Testing Market Overview

3 Manufacturer Bioburden Testing Business Introduction

3.1 Charles River Laboratories International Bioburden Testing Business Introduction

3.2 Sigma-Aldrich Bioburden Testing Business Introduction

3.3 SGS Bioburden Testing Business Introduction

3.4 Wuxi Pharmatech (CAYMAN) Bioburden Testing Business Introduction

3.5 Merck Bioburden Testing Business Introduction

3.6 Becton Dickinson Bioburden Testing Business Introduction

………………. Request free sample to get a complete Table of Content

About us

BusinessindustryReports.com is digital database of comprehensive market reports for global industries. As a market research company, we take pride in equipping our clients with insights and data that holds the power to truly make a difference to their business. Our mission is singular and well-defined – we want to help our clients envisage their business environment so that they are able to make informed, strategic and therefore successful decisions for themselves.

Media Contact

Business Industry Reports

Pune – India

sales@businessindustryreports.com

+19376349940

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Bioburden Testing Market Rapidly Growing in Medical Industry, Competitor Analysis and Top Key Players (Merck, Sigma-Aldrich, SGS, Becton Dickinson, Nelson Lab, ATS Labs) | Forecast 2019 - 2023 here

News-ID: 1851663 • Views:

More Releases from Business Industry Reports

Tetracaine Market Exhibits a Lucrative Growth Potential during 2021-2025 | Endo International, Nuvo Pharma, Ferndale Pharma, Galen, Jazz Pharma, Paladin Labs, St Renatus, MSK Pharma
Tetracaine Market Exhibits a Lucrative Growth Potential during 2021-2025 | Endo …
BusinessIndustryReports has recently broadcasted a new study to its broad research portfolio, which is titled as “Global Tetracaine Market” Research Report 2021 provides an in-depth analysis of the Tetracaine with the forecast of market size and growth. The analysis includes addressable market, market by volume, market share by business type and by segment (external and in-house). The research study examines the Tetracaine on the basis of a number of criteria,
Cyber Warfare Market Evenly Poised To Reach A Market Value of US$ By Share, Size and Leading Players (Lockheed Martin, BAE System, Boeing, General Dynamic, Raytheon) | Forecast to 2025
Cyber Warfare Market Evenly Poised To Reach A Market Value of US$ By Share, Size …
Overview of Global Cyber Warfare Market: This report provides in-depth study of “Global Cyber Warfare Market 2021” using SWOT analysis i.e. Strength, Weakness, Opportunities, and Threat to the organization. The Cyber Warfare Market report also provides an in-depth survey of key players in the market organization. According to the market research study, the Cyber Warfare is virtual conflict between state, organization, or country by the use of computer technology to disrupt activities
Covid-19 Impact on Cranio Maxillofacial Implant Market 2021-2025: Business Growth by Top Key Company’s - J&J, Medtronic, B Braun, Boston Medical, Integra, Stryker, Zimmer, CONMED
Covid-19 Impact on Cranio Maxillofacial Implant Market 2021-2025: Business Growt …
Overview of Global Cranio Maxillofacial Implant Market: This report provides in-depth study of “Global Cranio Maxillofacial Implant Market 2021” using SWOT analysis i.e. Strength, Weakness, Opportunities, and Threat to the organization. The Cranio Maxillofacial Implant Market report also provides an in-depth survey of key players in the market organization. According to the market research study, Craniomaxillofacial Implants are medical implants used in surgeries of maxillofacial region such as, head, face, neck, oral,
Beginning of the bloom: The Rise of the Biohacking Market 2021-2025 | Global Key Players - Apple, Fitbit, Synbiota, THE ODIN, HVMN, Thync Global, Moodmetric
Beginning of the bloom: The Rise of the Biohacking Market 2021-2025 | Global Key …
Global Biohacking Market Synopsis: The report covers a forecast and an analysis of the Biohacking Market on a global and regional level. The study provides historical data for 2015, 2016, 2017 and 2018 along with a forecast from 2020 to 2025 based on revenue (USD Million) and volume (Kilotons). The study includes drivers and restraints of the Biohacking Market along with the impact they have on the demand over the forecast

All 5 Releases


More Releases for Bioburden

Bioburden Testing Market Insights: Emerging Opportunities, Size Estimation & For …
" The global Bioburden Testing Market is experiencing substantial growth, driven by several key factors including the increasing stringency of regulatory requirements, the growing focus on patient safety, and the rising adoption of sterile products. Technological advancements, particularly in rapid microbial detection methods and automated testing systems, are further fueling market expansion. Bioburden testing plays a critical role in ensuring the safety and quality of pharmaceutical products, medical devices, food and
Bioburden Testing Market Facts, Future Scenarios, Growth and Analytical Insights …
Bioburden testing is a process of measuring viable microorganisms on medical devices, raw material, or package. The process helps in determining parameters for its sterilization process to ensure safety and effectiveness of medical devices. It further aids in routine monitoring of raw material, components, and assembly processes in manufacturing process. The bioburden testing is used for assessment of cleaning processes and packaging of products is conducted to ensure safety. 𝐋𝐢𝐬𝐭 𝐨𝐟
Bioburden Testing Market Future Scope Including Top Players Sigma-Aldrich, SGS
A new business intelligence report released by HTF MI with title “Global Bioburden Testing Market Size, Status and Forecast 2025” that targets and provides comprehensive market analysis with future prospects to 2023. The analysts of the study have garnered extensive research methodologies and data sources (i.e Secondary & Primary Sources) in order to generate collective and useful information that delivers latest market undercurrents and industry trends. Request Sample Report @:
Bioburden Testing Market | Key Growth Factors and Forecast up to 2023
Bioburden is defined as the number in terms of percentage, colony or cell count of bacteria that thrive on a given unsterilized surface. Bioburden testing, also known as microbial limit testing provides quantification of the bacterial cell cultures on a given unsterilized surface. The major application of bioburden testing lies in implant fixation procedures that require testing ofcertain tolerable bioburden limit before implantation in the human body. The standard for
Bioburden Testing Market: Key Trends and Forecast Research Report 2023
Bioburden is defined as the number in terms of percentage, colony or cell count of bacteria that thrive on a given unsterilized surface. Bioburden testing, also known as microbial limit testing provides quantification of the bacterial cell cultures on a given unsterilized surface. The major application of bioburden testing lies in implant fixation procedures that require testing ofcertain tolerable bioburden limit before implantation in the human body. The standard for
Bioburden Testing Market : Analysis & Trends 2023
Bioburden is defined as the number in terms of percentage, colony or cell count of bacteria that thrive on a given unsterilized surface. Bioburden testing, also known as microbial limit testing provides quantification of the bacterial cell cultures on a given unsterilized surface. The major application of bioburden testing lies in implant fixation procedures that require testing ofcertain tolerable bioburden limit before implantation in the human body. The standard for